Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1963 1
1965 1
1971 2
1972 1
1973 1
1974 1
1976 2
1977 1
1978 1
1984 2
1986 1
1987 1
1988 2
1991 6
1992 2
1993 5
1994 6
1995 6
1996 8
1997 2
1998 5
1999 6
2000 6
2001 5
2002 5
2003 5
2004 12
2005 6
2006 7
2007 5
2008 14
2009 11
2010 11
2011 13
2012 13
2013 20
2014 13
2015 11
2016 16
2017 10
2018 14
2019 10
2020 11
2021 31
2022 17
2023 21
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

324 results

Results by year

Filters applied: . Clear all
Page 1
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study.
Qin S, Chan SL, Gu S, Bai Y, Ren Z, Lin X, Chen Z, Jia W, Jin Y, Guo Y, Hu X, Meng Z, Liang J, Cheng Y, Xiong J, Ren H, Yang F, Li W, Chen Y, Zeng Y, Sultanbaev A, Pazgan-Simon M, Pisetska M, Melisi D, Ponomarenko D, Osypchuk Y, Sinielnikov I, Yang TS, Liang X, Chen C, Wang L, Cheng AL, Kaseb A, Vogel A; CARES-310 Study Group. Qin S, et al. Among authors: yang ts. Lancet. 2023 Sep 30;402(10408):1133-1146. doi: 10.1016/S0140-6736(23)00961-3. Epub 2023 Jul 24. Lancet. 2023. PMID: 37499670 Clinical Trial.
Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.
Saltz LB, Clarke S, Díaz-Rubio E, Scheithauer W, Figer A, Wong R, Koski S, Lichinitser M, Yang TS, Rivera F, Couture F, Sirzén F, Cassidy J. Saltz LB, et al. Among authors: yang ts. J Clin Oncol. 2008 Apr 20;26(12):2013-9. doi: 10.1200/JCO.2007.14.9930. J Clin Oncol. 2008. PMID: 18421054 Corrected and republished. Clinical Trial.
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial.
Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S, Kim JS, Luo R, Feng J, Ye S, Yang TS, Xu J, Sun Y, Liang H, Liu J, Wang J, Tak WY, Pan H, Burock K, Zou J, Voliotis D, Guan Z. Cheng AL, et al. Among authors: yang ts. Lancet Oncol. 2009 Jan;10(1):25-34. doi: 10.1016/S1470-2045(08)70285-7. Epub 2008 Dec 16. Lancet Oncol. 2009. PMID: 19095497 Clinical Trial.
Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer.
Cassidy J, Clarke S, Díaz-Rubio E, Scheithauer W, Figer A, Wong R, Koski S, Lichinitser M, Yang TS, Rivera F, Couture F, Sirzén F, Saltz L. Cassidy J, et al. Among authors: yang ts. J Clin Oncol. 2008 Apr 20;26(12):2006-12. doi: 10.1200/JCO.2007.14.9898. J Clin Oncol. 2008. PMID: 18421053 Clinical Trial.
What Is Your Diagnosis?
Little A, Tollefson CR, Lee AM, Yang TS, Moore TM. Little A, et al. Among authors: yang ts. J Am Vet Med Assoc. 2021 Nov 12;260(1):33-36. doi: 10.2460/javma.19.11.0583. J Am Vet Med Assoc. 2021. PMID: 34780355 Free article. No abstract available.
Determination of Postmortem Interval in Mice.
Howie RR, McKinney MM, Tataryn NM, Cole AL, Dupont WD, Yang TS, Gibson-Corley KN. Howie RR, et al. Among authors: yang ts. J Am Assoc Lab Anim Sci. 2024 Mar 12. doi: 10.30802/AALAS-JAALAS-23-000107. Online ahead of print. J Am Assoc Lab Anim Sci. 2024. PMID: 38471755
What is your diagnosis? Ovarian mass in a mare.
Parsley AL, Rasche BL, Yang TS, Gruber EJ. Parsley AL, et al. Among authors: yang ts. Vet Clin Pathol. 2023 May;52 Suppl 2:134-137. doi: 10.1111/vcp.13161. Epub 2022 Sep 9. Vet Clin Pathol. 2023. PMID: 36085247 No abstract available.
324 results